What I do at MMV:
My role as Director, Clinical Sciences within the Product Development team is to lead the development of clinical strategy and clinical study design for early and late phase projects. I am also involved in writing clinical documents, data analysis and interpretation to ensure efficient and effective clinical development of antimalarials across MMV’s portfolio.
Why I work at MMV:
I grew up in malaria-endemic countries and have always been motivated and committed to improving the health and lives of vulnerable populations at risk of infectious diseases. MMV’s mission resonates with me and I joined MMV to contribute to developing new effective and affordable treatments to hopefully eradicate this terrible disease.
More about me:
I am a PharmD by training, specialized in clinical development of molecules from first-in-man to post-approval stage with strong expertise in clinical pharmacology, PK/PD and broad knowledge in formulation and regulatory affairs. Over the last 15 years I had the opportunity to lead early phase programmes, clinical development strategies and clinical pharmacology trials in diverse therapeutic areas in the pharmaceutical industry and in a not-for profit organization.
Ask me about:
Drug development, combinations, clinical trials, development in special populations e.g. pediatrics and pregnant women, clinical pharmacology, PKPD and PBPK. On a more personal note, you can ask me about Africa…its people, its music, its pulse, and its energy!